NewLeaf Symbiotics Raises $7 Million in Series A Financing From RockPort Capital, Open Prairie Ventures and Pangaea Ventures
1/10/2013 9:20:32 AM
ST. LOUIS--(BUSINESS WIRE)--NewLeaf Symbiotics, Inc. today announced the completion of a $7.0 million round of financing. Investors in the syndicate include Rockport Capital, Open Prairie Ventures, Pangaea Ventures, and several individuals. NewLeaf Symbiotics is an agricultural biotech firm that is commercializing a family of beneficial bacteria known as PPFMs (Pink Pigmented Facultative Methylotrophs). PPFMs are ubiquitous in nature and have been shown to improve plant health, promote early growth, and increase crop yield. Tom Laurita, NewLeaf Symbiotics’ CEO, commented on the investment partners, "We have assembled a terrific syndicate that will definitely be helpful to the company as we move through the next stage of development."